Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

PCYC

(MM) (PCYC)

(MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PCYC
FechaHoraFuenteTítuloSímboloCompañía
15/06/201514:02Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PCYC(MM)
10/06/201511:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PCYC(MM)
05/06/201506:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:PCYC(MM)
01/06/201510:24Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PCYC(MM)
31/05/201508:05PR Newswire (US)Ibrutinib (IMBRUVICA®) Phase Ib/II Data Show Promise in Patients with Chronic Graft-Versus-Host-DiseaseNASDAQ:PCYC(MM)
30/05/201506:31PR Newswire (US)Phase III HELIOS Study Results Show Ibrutinib (IMBRUVICA®) Combination Therapy Significantly Increased Progression-Free Surv...NASDAQ:PCYC(MM)
28/05/201518:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201508:00PR Newswire (US)Ibrutinib (IMBRUVICA®) in Combination with Anti-PD-L1 Antibody (MEDI4736) Study Commences for Patients with Two Relapsed/Ref...NASDAQ:PCYC(MM)
26/05/201507:48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCYC(MM)
26/05/201507:48Edgar (US Regulatory)(25-NSE)NASDAQ:PCYC(MM)
26/05/201507:40Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PCYC(MM)
26/05/201506:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201506:10Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:PCYC(MM)
22/05/201507:04PR Newswire (US)European Medicines Agency Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) to Treat Waldenstrom's...NASDAQ:PCYC(MM)
20/05/201509:06The Motley FoolSWOT Analysis of Gilead Sciences Inc. StockNASDAQ:PCYC(MM)
14/05/201507:58Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PCYC(MM)
13/05/201516:21PR Newswire (US)New ibrutinib (IMBRUVICA®) Data to be Showcased at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:PCYC(MM)
05/05/201516:56Dow Jones NewsAbbVie Wraps Up Large Debt Sale for Pharmacyclics DealNASDAQ:PCYC(MM)
05/05/201516:38Dow Jones NewsAbbVie Wraps Up Large Debt Sale For Pharmacyclics DealNASDAQ:PCYC(MM)
05/05/201513:40Dow Jones NewsAbbVie Launches Large Debt Sale for Pharmacyclics DealNASDAQ:PCYC(MM)
05/05/201508:38Analyst Ratings NetworkZacks Lowers Pharmacyclics to Hold (PCYC)NASDAQ:PCYC(MM)
04/05/201516:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PCYC(MM)
04/05/201509:27Analyst Ratings NetworkPharmacyclics Lifted to "Buy" at Zacks (PCYC)NASDAQ:PCYC(MM)
01/05/201517:58Dow Jones NewsAbbVie Extends Exchange Offer to Acquire PharmacyclicsNASDAQ:PCYC(MM)
01/05/201508:15PR Newswire (US)Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business UpdatesNASDAQ:PCYC(MM)
23/04/201513:44Dow Jones NewsAbbVie Profit Rises on Broad Sales Growth -- UpdateNASDAQ:PCYC(MM)
23/04/201512:12Dow Jones NewsAbbVie Profit Rises 4.3%NASDAQ:PCYC(MM)
23/04/201512:08Dow Jones NewsAbbVie Profit Rises 4.3% on Broad Sales GrowthNASDAQ:PCYC(MM)
23/04/201510:34The Motley FoolHumira Propels AbbVie Inc. to a Solid First QuarterNASDAQ:PCYC(MM)
20/04/201511:16Analyst Ratings NetworkBMO Capital Markets Reiterates "Positive" Rating for Pharmacyclics (PCYC)NASDAQ:PCYC(MM)
 Showing the most relevant articles for your search:NASDAQ:PCYC